Publication | Open Access

Use of aromatase inhibitors in poor-responder patients receiving GnRH antagonist protocols

Aromatase InhibitorsPoor-responder PatientsPsychotropic MedicationPharmacologyGnrh Antagonist ProtocolsClinical PharmacologyAromatasePharmacotherapyEndocrinologyMedicineDrug Discovery